SBIR/STTR Research Award

PARP Inhibitors for Chemotherapy of Brain Tumors

Award identifier 7b4310f6bba461b4078fb362c9721eb519c0fc2ae04cd74801ba85860aee869fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$107,000

Program and phase

SBIR · Phase I

Award year

2004

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Open in CaptureIQRequest Access

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Guilford Pharmaceuticals, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2004-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The objective for the proposed study is to determine the feasibility of using novel small molecule poly(ADPribose) polymerase (PARP) inhibitors as an adjunct treatment to enhance the antitumor activities of chemotherap

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

SmartSoloChatGPTClaudePerplexityGrokGemini

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.